Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016.

作者: Alessandro Lugli , Richard Kirsch , Yoichi Ajioka , Fred Bosman , Gieri Cathomas

DOI: 10.1038/MODPATHOL.2017.46

关键词: HematopathologyGrading (tumors)Tumor buddingColorectal cancerPathologyBuddingLymph nodeCarcinomaSurgical pathologyMedicine

摘要: Tumor budding is a well-established independent prognostic factor in colorectal cancer but standardized method for its assessment has been lacking. The primary aim of the International Budding Consensus Conference (ITBCC) was to reach agreement on an international, evidence-based scoring system tumor cancer. ITBCC included nine sessions with presentations, pre-meeting survey and e-book covering key publications 'Grading Recommendation Assessment, Development Evaluation' used determine strength recommendations quality evidence. following 10 statements achieved consensus: defined as single cell or cluster consisting four cells less (22/22, 100%). predictor lymph node metastases pT1 (23/23, survival stage II should be taken into account along other clinicopathological features multidisciplinary setting counted H&E (19/22, 86%). Intratumoral exists shown related metastasis assessed one hotspot (in field measuring 0.785 mm2) at invasive front A three-tier count order facilitate risk stratification grade are not same guidelines/protocols reporting Members were able strong consensus reporting. It proposed that this incorporated staging systems.

参考文章(89)
Kazuhito Ichikawa, Takahiro Fujimori, Shigeki Tomita, Hiroyuki Mitomi, Mayuko Yamauchi, The brand new trend of colorectal carcinoma pathology Nihon rinsho. Japanese journal of clinical medicine. ,vol. 72, pp. 63- 70 ,(2014)
F. Petrelli, E. Pezzica, M. Cabiddu, A. Coinu, K. Borgonovo, M. Ghilardi, V. Lonati, D. Corti, S. Barni, Tumour Budding and Survival in Stage II Colorectal Cancer: a Systematic Review and Pooled Analysis Journal of Gastrointestinal Cancer. ,vol. 46, pp. 212- 218 ,(2015) , 10.1007/S12029-015-9716-1
Rondell P. Graham, Robert A. Vierkant, Lori S. Tillmans, Alice H. Wang, Peter W. Laird, Daniel J. Weisenberger, Charles F. Lynch, Amy J. French, Susan L. Slager, Yassaman Raissian, Joaquin J. Garcia, Sarah E. Kerr, Hee Eun Lee, Stephen N. Thibodeau, James R. Cerhan, Paul J. Limburg, Thomas C. Smyrk, Tumor Budding in Colorectal Carcinoma: Confirmation of Prognostic Significance and Histologic Cutoff in a Population-based Cohort. The American Journal of Surgical Pathology. ,vol. 39, pp. 1340- 1346 ,(2015) , 10.1097/PAS.0000000000000504
Eva Karamitopoulou, Alessandro Lugli, Ioannis Panayiotides, Petros Karakitsos, George Peros, George Rallis, Efstratios S Patsouris, Luigi Terracciano, Inti Zlobec, Systematic assessment of protein phenotypes characterizing high-grade tumour budding in mismatch repair-proficient colorectal cancer. Histopathology. ,vol. 57, pp. 233- 243 ,(2010) , 10.1111/J.1365-2559.2010.03615.X
Giacomo Puppa, Carlo Senore, Kieran Sheahan, Michael Vieth, Alessandro Lugli, Inti Zlobec, Sara Pecori, Lai Mun Wang, Cord Langner, Hiroyuki Mitomi, Takatoshi Nakamura, Masahiko Watanabe, Hideki Ueno, Jacques Chasle, Stephen A Conley, Paulette Herlin, Gregory Y Lauwers, Mauro Risio, Diagnostic reproducibility of tumour budding in colorectal cancer: a multicentre, multinational study using virtual microscopy. Histopathology. ,vol. 61, pp. 562- 575 ,(2012) , 10.1111/J.1365-2559.2012.04270.X
Viktor H. Koelzer, Inti Zlobec, Alessandro Lugli, Tumor budding in colorectal cancer—ready for diagnostic practice? Human Pathology. ,vol. 47, pp. 4- 19 ,(2016) , 10.1016/J.HUMPATH.2015.08.007
Koichi Nakadoi, Shinji Tanaka, Hiroyuki Kanao, Motomi Terasaki, Sayaka Takata, Shiro Oka, Shigeto Yoshida, Koji Arihiro, Kazuaki Chayama, Management of T1 colorectal carcinoma with special reference to criteria for curative endoscopic resection Journal of Gastroenterology and Hepatology. ,vol. 27, pp. 1057- 1062 ,(2012) , 10.1111/J.1440-1746.2011.07041.X
lsabel Hostettler, ABCG5-positivity in tumor buds is an indicator of poor prognosis in node-negative colorectal cancer patients World Journal of Gastroenterology. ,vol. 16, pp. 732- 739 ,(2010) , 10.3748/WJG.V16.I6.732